Study Start Date definition

Study Start Date means the esti- mated date on which the clinical trial will be open for recruitment of human subjects, or the actual date on which the first human subject was enrolled.
Sample 1Sample 2Sample 3
Study Start Date means the date set forth in Schedule “A”, as the earliest date on which the Recipient can begin incurring Study Costs;
Sample 1Sample 2Sample 3
Study Start Date as specified in accordance with Annex CS(chedule of Study).
Sample 1Sample 2

Examples of Study Start Date in a sentence

  • The Contractor shall not commence provision of the Study until Study Start Date, as identified in accordance with Annex C (Schedule of Study) and shall ensure that the Deliverables are furnished to the Principal on or before each relevant Study Milestone.

  • The Contractor shall not commence provision of the Study until Study Start Date, as identified in accordance with Annex C: Schedule of Study and shall ensure that the Deliverables are furnished to the Principal on or before each relevant Study Milestone.

  • If the first Business Day after thirty (30) Calendar Days following the completion of the prior Expedited Deliverability Study falls on a date within the above-described Class Year decision and settlement period, the Expedited Deliverability Study will begin on the first Business Day after ten (10) Calendar Days following the Class Year Study Start Date immediately following the above-described Class Year decision and settlement period.

  • The Contractor shall not commence provision of the Study until Study Start Date, as identified in accordance with Annex C: Schedule of the Study and shall ensure that the Deliverables are furnished to the Principal on or before each relevant Study Milestone.

  • Data collection included the following variables: The Trial Title; Xxxxxxxxxxxxxx.xxx Identifier; First Received Date (the date on which summary clinical study protocol information was first submitted to the XxxxxxxxXxxxxx.xxx registry); Study Start Date; Study Completion Date; Sponsors; Collaborators; Study Type (Interventional); Condition; Intervention; Total Number of Patients; Mean Patients Age.

  • The initial cost allocation, with some exceptions, shall determine the SUFs required for the reliable interconnection of all Developer projects that have met the milestones identified in specific sections of Attachment S on or before the Study Start Date.

  • The Study is scheduled to begin on Study Start Date and should be completed on Study End Date.

  • Technical Specification and Schedule of Study; (jj) Study Start Date Schedule of Study).

  • Year (1) Class Year 2001 Developer projects that have accepted their Project Cost Allocation prior to the Study Start Date, or (2) Class Year 2002 Developer Projects that have accepted their Project Cost Allocation pursuant to the terms of this Settlement Agreement.

  • ANNEX C: SCHEDULE OF STUDY Study Start Date: Commencement Date of the Agreement Study Milestones: According to Section 4.4. of the Technical Specification Deliverables: According to Part 4.5 of the Technical Specification Defects Date: as set in column “Approval by RB Rail AS” in the table “Time schedule of deliverables and approval” in Section 4.5.3 of the Technical Specification.


More Definitions of Study Start Date

Study Start Date as specified in accordance with Annex C: Schedule of Study. (nn) “VAT”, value added tax;
Sample 1
Study Start Date as specified in accordance with Annex C: Schedule of the Study.
Sample 1

Related to Study Start Date

  • Supply Start Date means the date(s) specified in clause 2.8;

  • Start Date for Term Calculation Purposes Only: Regardless of actual award/effective date of Contract, for Agreement “term” calculation purposes only, the Agreement “start date” is the last day of the month that Award Notifications are anticipated as published in the Solicitation. Example: If the anticipated award date published in the Solicitation is August 27, 2020 but extended negotiations delay award until September 24, 2020 the end date of the resulting initial “two-year” term Agreement, (which is subject to an extension(s)) will still be August 31, 2022 in this example

  • Contract Start Date means the date specified in your Contract for Signature asthe date this Contract starts;

  • Project Start Date means the first Milestone Start Date specified in Schedule B;

  • Term Start Date has the meaning set forth in Section 1.01.

  • Study Completion means the database for the Study has been locked and all Essential Documents have been provided to the Sponsor, including a copy of the letter from the Reviewing HREC acknowledging receipt of the final report and/or closure letter from the Principal Investigator.

  • Application Review Start Date means the later date of either the date on which the District issues its written notice that the Applicant has submitted a completed Application or the date on which the Comptroller issues its written notice that the Applicant has submitted a completed Application and as further identified in Section 2.3.A of this Agreement.

  • Study Period means the period commencing at 9:00 a.m. on the date hereof, and continuing through 5:00 p.m. on the Closing Date.

  • Start means the relevant Compounded Index value on the day falling the Relevant Number of Index Days prior to the first day of the relevant Interest Period.

  • Service Start Date means the date on which services were first supplied under this Agreement.

  • Commissioning Period means, with respect to each Subproject, the period commencing upon the first delivery of Feed Gas to the Subproject in accordance with Sections 4.8 and 11.1 of the Agreement continuing through achievement of RFSU, commissioning, Start Up, Performance Testing and achievement of Substantial Completion for such Subproject.

  • Target Completion Date has the meaning given such term in Section 3.3(b).

  • Services Start Date means the date as set out in the Specification (Schedule 1);

  • Completion Date means the date of completion of the Services by the Service Provider as certified by the Procuring Entity

  • Study Site means the location(s) under the control of the Institution where the Study is actually conducted as set out in Schedule 1.

  • Phase 2 means the second implementation phase of this section, beginning June 1, 2022 and continuing thereafter.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • The Completion Date means the date of completion of the Works as certified by the Employer’s Representative.

  • System Impact Study means an assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights. System Protection Facilities: “System Protection Facilities” shall refer to the equipment required to protect (i) the Transmission System, other delivery systems and/or other generating systems connected to the Transmission System from faults or other electrical disturbance occurring at or on the Customer Facility, and (ii) the Customer Facility from faults or other electrical system disturbance occurring on the Transmission System or on other delivery systems and/or other generating systems to which the Transmission System is directly or indirectly connected. System Protection Facilities shall include such protective and regulating devices as are identified in the Applicable Technical Requirements and Standards or that are required by Applicable Laws and Regulations or other Applicable Standards, or as are otherwise necessary to protect personnel and equipment and to minimize deleterious effects to the Transmission System arising from the Customer Facility. Transmission Facilities:

  • Project Completion Date means the date on which the Completion Certificate is issued;

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Construction Start Date means the later to occur of the date on which Seller delivers to Buyer (a) a copy of the Notice to Proceed that Seller has delivered to the EPC Contractor for the Project, and (b) a written Certification substantially in the form attached hereto as Appendix IV-1.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Index Start Date means 19 January 2015.